US$ 24.27
bpc-157 uses research for athletes and injury treatment: Science, safety, and legal concerns BPC-157 Vial | BioHack London
Description
Executive Guidance: Protecting Clinical Integrity The transition of BPC-157 to Category 2 represents a clear enforcement priority regarding synthetic peptides

Dawicki W, Allen KJH, Jiao R, Malo ME, Helal M, Berger MS, et al

Nasally BPC 157 nasal spray is another option

They have shown encouraging outcomes

Do not administration by the intravenous route

Peer-reviewed RCT data in human tendon injury populations has not yet been published at scale
